|
EXCLUSIVE NEWS
|
The interview was conducted on 19 August 2010 with Mr. Hide Otake, President and Chief Executive Officer, and Dr. Yoko Yamaguchi, Co-founder of NANOEGG Research Laboratories Inc.
Product launch of Otokomae, NANOEGG’s Men’s Cosmetics brand – Company management members consisting of Mr. Hidehiko Otake, President and CEO, Dr. Yoko Yamaguchi, Board of Directors (R&D) and Co-founder, Mr. Joe Ng, Business Development Leader, seen here with Mr. Tsunoda, K-1 fighter and celebrity in Japan, as guest ambassador for NANOEGG’s Otokomae.
NANOEGG Research Laboratories Inc. is a research and development company focusing on drug delivery system (DDS) technologies, specifically transdermal delivery systems called NANOEGG® and NANOCUBE®.
|
|
|
The interview was conducted on 05 August 2010 with Mr. Steven Fang, Group Chief Executive Officer, CordLife Limited.
CordLife India Official Launch – Mr. Steven Fang addressed the media in a Press Room in Kolkata, India.
CordLife Ltd is a cord blood banking group based in Singapore and listed on the Australian Securities Exchange. The company and its subsidiaries are engaged in the provision of cord blood banking services, which involves the processing and storage of human stem cells.
|
|
The interview was conducted on 21 May 2010 with Professor Steven Myint, Executive Chairman, OnMedica Group.
Professor Steven Myint was in Singapore (Biopolis) to explore business opportunities and conduct feasibility studies for OnMedica Group. OnMedica.com provides high quality online promotional and educational campaigns to doctors and other healthcare professionals.
|
|
|
The interview was conducted on 05 August 2010 with Prof. Walter H. Gunzburg, Executive Chairman, Dr. Brian Salmons, President and Chief Executive Officer, SGAUSTRIA, AUSTRIANOVA Singapore Pte Ltd.
(From Left to Right) Dr. John Dangerfield, Head of Laboratory; Ms Toa Shuit Yan Pauline, Research Assistant; Dr. Brian Salmons, President and Chief Executive Officer; Prof. Walter H. Gunzburg, Executive Chairman
SGAUSTRIA specialises in bio-encapsulation of living cells, bacteria and therapeutic agents using cellulose sulphate technology. The company has laboratories in the Centros Building, Biopolis, Singapore.
|
|
The interview was conducted on 19 May 2010 with Chief Executive Officer, Eddie Liew, and Chief Scientist, Dr. Margam Chandrasekaran, of Bio-scaffold International (BSI).
Founded in 1999, Bio-Scaffold International Pte Ltd (BSI) initiated R&D efforts in collaboration with SIMTech on the technology development for scaffolds to be applied in Guided Tissue Engineering. Funded by Spring Singapore under the Local Enterprise Technical Assistance Scheme, the partnership resulted in a revolutionary technology for bio-scaffold processing. A joint patent with A*STAR was filed, and porous bio-scaffolds, Bioscaff, were developed using the technology. The interview was conducted on 19 May 2010 with Chief Executive Officer, Eddie Liew, and Chief Scientist, Dr. Margam Chandrasekaran, of Bio-scaffold International (BSI).
|
|
|
<< Start < Prev 1 2 3 Next > End >>
|
|
Page 1 of 3 |
|
GENEWIRED.com
A showcase for the innovations, inspirations and ideas from Singapore’s scientists, technopreneurs and companies, GeneWired.com is poised to be the focal point for the life sciences and biomedical interest community in Singapore and Asia Pacific. Genewired.com’s mission is to help generate dynamic interests in business technology topics and market trends from local and overseas counterparts, thereby supporting a social media-based community in Singapore.
Read More ABOUT US...
|
